NAMS Stock Analysis: Buy, Sell, or Hold?
NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares
$34.47
-0.43 (-1.23%)
▼
5d:
+1.77%
30d:
+5.51%
90d:
+1.03%
BUY
HIGH Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 05, 2026
28d
Smart Money Distribution
None View Scanner →
Strength: 6.3/10
Get Alerted When NAMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called NAMS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NAMS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: NAMS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: NAMS is currently trading at $34.47, which is considered slightly high relative to its 30-day fair value range of $30.25 to $34.22.
Technical Outlook: Technically, NAMS is showing sideways momentum. Immediate support is located at $29.70, while resistance sits at $36.34.
Market Sentiment: NAMS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $49.67 (+42.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NAMS is showing sideways momentum. Immediate support is located at $29.70, while resistance sits at $36.34.
Market Sentiment: NAMS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $49.67 (+42.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$30.25 -
$34.22
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.3% below Wall St target ($49.67)
Trading Range Analysis
30-Day Trading Range
$30.25 -
$34.22
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$29.70
Resistance Level
$36.34
Current Trend
Sideways
Technical data as of
Jul 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-26.46
Wall Street Target
$49.67
(+42.3%)
Revenue Growth (YoY)
2.1%
Share & Embed Analysis
Last updated: July 07, 2026 10:23 AM ET
Data refreshes hourly during market hours. Next update: 11:23 AM
Data refreshes hourly during market hours. Next update: 11:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Louis G Lange
SELL
44619 shares
2026-03-11
Johannes Jacob Piete Kas…
SELL
101409 shares
2026-03-09
Johannes Jacob Piete Kas…
SELL
94124 shares
2026-03-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 64 BUY |
Advanced NAMS Option Strategies
Professional options setups generated by AI based on today's NAMS price and gamma walls.
